Human solid tumors contain high endothelial venules: Association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer

Cancer Research

Volumn 71, Issue 17, 2011, Pages 5678-5687

  Martinet, Ludovic ^a   Garrido, Ignacio ^a,c   Filleron, Thomas ^c   Guellec, Sophie Le ^c   Bellard, Elisabeth ^a   Fournie, Jean Jacques ^b,d   Rochaix, Philippe ^c   Girard, Jean Philippe ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b France   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; CD8 ANTIGEN;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE INFILTRATION; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER RELAPSE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DENSITY; COHORT ANALYSIS; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MELANOMA; MEMORY T LYMPHOCYTE; METASTASIS; OVARY CARCINOMA; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE INFILTRATION; TH1 CELL; TUMOR LOCALIZATION; UPREGULATION; VASCULAR ENDOTHELIUM; VENULE;

B-LYMPHOCYTES; BREAST NEOPLASMS; COHORT STUDIES; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, LYMPHATIC; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80052236068     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0431     Document Type: Article

References (38)

1. Dunn GP, Old L J, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329-60.
2. Disis ML. Immune regulation of cancer. J Clin Oncol 2010;28:4531-8.
3. Denkert C, Loibl S, Noske A, Roller M, Muller BM, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010;28:105-13.
4. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol 2008;8:59-73.
5. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-66.
6. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-4.
7. Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009;27:5944-51.
8. Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008;26:4410-7.
9. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-13.
10. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005;102:18538-43.
11. +T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci U S A 2007;104:3360-5.
12. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-34.
13. Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, et al. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 2008;14:28-36.
14. Dirkx AE, Oude Egbrink MG, Kuijpers MJ, Van Der Niet ST, Heijnen VV, Bouma-ter Steege JC, et al. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003;63:2322-9.
15. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-57.
16. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-78.
17. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004;22:129-56.
18. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6:205-17.
19. Girard JP. High-endothelial venule-like vessels in human chronic inflammatory diseases. In: Aird W, editor. Endothelial biomedicine. Cambridge, UK: Cambridge University Press; 2007. p. 1419-30.
20. Kobayashi M, Mitoma J, Nakamura N, Katsuyama T, Nakayama J, Fukuda M. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc Natl Acad Sci U S A 2004;101:17807-12.
21. Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988;107:1853-62.
22. Yeh JC, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, et al. Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase. Cell 2001;105:957-69.
23. Duijvestijn AM, Horst E, Pals ST, Rouse BN, Steere AC, Picker LJ, et al. High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 1988;130:147-55.
24. Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999;155:2043-55.
25. Mitsuoka C, Sawada-Kasugai M, Ando-Furui K, Izawa M, Nakanishi H, Nakamura S, et al. Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X. J Biol Chem 1998;273:11225-33.
26. Jeannin P, Herbault N, Delneste Y, Magistrelli G, Lecoanet-Henchoz S, Caron G, et al. Human effector memory T cells express CD86: a functional role in naive T cell priming. J Immunol 1999;162:2044-8.
27. Toppila S, Paavonen T, Nieminen MS, Hayry P, Renkonen R. Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants [see comments]. Am J Pathol 1999;155:1303-10.
28. Canete JD, Celis R, Moll C, Izquierdo E, Marsal S, Sanmarti R, et al. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis 2009;68:751-756.
29. Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004;64:2941-55.
30. Sharma P, Shen Y, Wen S, Yamada S, Jungbluth AA, Gnjatic S, et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A 2007;104:3967-72.
31. Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS. Tumorin-filtrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 2007;25:869-75.
32. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 2005;102:9571-6.
33. + T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A 2009;106:17469-74.
34. Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004;5:141-9.
35. Yu P, Fu YX. Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev 2008;19:285-94.
36. Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol 2010;10:236-47.
37. Kershaw MH, Teng MW, Smyth MJ, Darcy PK. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol 2005;5:928-40.
38. Lacorre DA, Baekkevold ES, Garrido I, Brandtzaeg P, Haraldsen G, Amalric F, et al. Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 2004;103:4164-72.